Christine Lu1, Eleanor G Hutchens2,3, Leon S Farhy2,4, Heather G Bonner5, Paul M Suratt5, Christopher R McCartney2,3. 1. University of Virginia School of Medicine, Charlottesville, Virginia, USA. 2. Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA. 3. Center for Research in Reproduction, University of Virginia School of Medicine, Charlottesville, Virginia, USA. 4. Center for Diabetes Technology, University of Virginia School of Medicine, Charlottesville, Virginia, USA. 5. Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Abstract
OBJECTIVE: During the early follicular phase, sleep-related luteinizing hormone (LH) pulse initiation is positively associated with brief awakenings but negatively associated with rapid eye movement (REM) sleep. The relationship between sleep architecture and LH pulse initiation has not been assessed in other cycle stages or in women with polycystic ovary syndrome (PCOS). DESIGN AND METHODS: We performed concomitant frequent blood sampling (LH pulse analysis) and polysomnography on 8 normal women (cycle day 7-11) and 7 women with PCOS (at least cycle day 7). RESULTS: In the normal women, the 5 min preceding LH pulses contained more wake epochs and fewer REM epochs than the 5 min preceding randomly determined time points (wake: 22.3 vs. 9.1%, p = 0.0111; REM: 4.4 vs. 18.8%, p = 0.0162). However, LH pulse initiation was not related to wake or REM epochs in PCOS; instead, the 5 min preceding LH pulses contained more slow-wave sleep (SWS) than the 5 min before random time points (20.9 vs. 6.7%, p = 0.0089). Compared to the normal subjects, the women with PCOS exhibited a higher REM-associated LH pulse frequency (p = 0.0443) and a lower proportion of wake epochs 0-5 min before LH pulses (p = 0.0205). CONCLUSIONS: Sleep-related inhibition of LH pulse generation during the later follicular phase is normally weakened by brief awakenings and strengthened by REM sleep. In women with PCOS, LH pulse initiation is not appropriately discouraged by REM sleep and may be encouraged by SWS; these abnormalities may contribute to a high sleep-related LH pulse frequency in PCOS.
RCT Entities:
OBJECTIVE: During the early follicular phase, sleep-related luteinizing hormone (LH) pulse initiation is positively associated with brief awakenings but negatively associated with rapid eye movement (REM) sleep. The relationship between sleep architecture and LH pulse initiation has not been assessed in other cycle stages or in women with polycystic ovary syndrome (PCOS). DESIGN AND METHODS: We performed concomitant frequent blood sampling (LH pulse analysis) and polysomnography on 8 normal women (cycle day 7-11) and 7 women with PCOS (at least cycle day 7). RESULTS: In the normal women, the 5 min preceding LH pulses contained more wake epochs and fewer REM epochs than the 5 min preceding randomly determined time points (wake: 22.3 vs. 9.1%, p = 0.0111; REM: 4.4 vs. 18.8%, p = 0.0162). However, LH pulse initiation was not related to wake or REM epochs in PCOS; instead, the 5 min preceding LH pulses contained more slow-wave sleep (SWS) than the 5 min before random time points (20.9 vs. 6.7%, p = 0.0089). Compared to the normal subjects, the women with PCOS exhibited a higher REM-associated LH pulse frequency (p = 0.0443) and a lower proportion of wake epochs 0-5 min before LH pulses (p = 0.0205). CONCLUSIONS: Sleep-related inhibition of LH pulse generation during the later follicular phase is normally weakened by brief awakenings and strengthened by REM sleep. In women with PCOS, LH pulse initiation is not appropriately discouraged by REM sleep and may be encouraged by SWS; these abnormalities may contribute to a high sleep-related LH pulse frequency in PCOS.
Authors: C A Eagleson; M B Gingrich; C L Pastor; T K Arora; C M Burt; W S Evans; J C Marshall Journal: J Clin Endocrinol Metab Date: 2000-11 Impact factor: 5.958
Authors: N D Shaw; J P Butler; S Nemati; T Kangarloo; M Ghassemi; A Malhotra; J E Hall Journal: J Clin Endocrinol Metab Date: 2014-12-09 Impact factor: 5.958
Authors: Michael L Johnson; Lenore Pipes; Paula P Veldhuis; Leon S Farhy; David G Boyd; William S Evans Journal: Anal Biochem Date: 2008-07-04 Impact factor: 3.365
Authors: Bob Z Sun; Tairmae Kangarloo; Judith M Adams; Patrick Sluss; Donald W Chandler; David T Zava; John A McGrath; David M Umbach; Natalie D Shaw Journal: J Clin Endocrinol Metab Date: 2019-06-01 Impact factor: 5.958
Authors: Jonathon Penix; R Anthony DeFazio; Eden A Dulka; Santiago Schnell; Suzanne M Moenter Journal: R Soc Open Sci Date: 2020-08-12 Impact factor: 2.963